期刊文献+

用竞争结合法检测HLAⅠ类分子抗原呈递能力 被引量:2

An useful method to analysis MHC class Ⅰ peptide binding
原文传递
导出
摘要 目的 建立弱酸处理后荧光素标记肽竞争结合法分析MHCⅠ类分子抗原呈递能力的方法 ,并评估其实用性。方法 pH2 .7~ 3.1的柠檬酸缓冲液对B淋巴母细胞进行短时处理后 ,即用IMDM培养液中和pH ,然后加入β2微球蛋白、荧光素标记的 9肽及竞争肽共同孵育 ,FACs检测细胞表面的平均荧光强度 ,以达到 5 0 %抑制所需的竞争肽浓度作为衡量竞争肽与MHC分子结合能力的指标。结果 通过不同pH的柠檬酸缓冲液处理、处理后不同时间加 β2微球蛋白和 /或荧光素标记肽、加入不同稀释度的竞争肽等角度 ,对方法进行评估 ,结果显示本方法操作简便、结果可靠、非特异性吸附小。结论 在排除其它MHCⅠ类分子的干扰后 ,本方法适合在国情条件下广泛开展MHCⅠ类分子抗原呈递能力及T细胞肽表位筛选等研究。 Objective To establish and evaluate a method of competition binding assay to MHC class Ⅰ molecules based on mild acid treatment described by van der Burg. Methods BLCL cells were treated with ice-cold citric acid-phosphat buffer (pH2.7-3.1) and buffered immediately using IMDM. After washing with IMDM, cells were incubated with β2m, fluorescein labeled reference peptide and competitor peptide. The mean fluorescence value was tested by a FACscan. Results β2m or FL-peptide were added after acid treatment with different time and pH, and a series end concentration of competitor peptide were incubated with FL-peptide. The results suggested that the method is easy to perform, sensitive and has low nonspecific adhering to other cell components. Conclusion The assay has a number of advantages compared to other method. The interference from other MHC class Ⅰ molecules was excluded. So the method can be used to investigate the peptide-MHC class Ⅰ binding and screen the T cell epitopes.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2003年第12期982-984,共3页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目 (3 980 0 13 1)
关键词 竞争结合法 检测 HLAⅠ类分子抗原 呈递能力 MHC class Ⅰ Peptide Competition binding assay
  • 相关文献

同被引文献11

  • 1王德心.药物开发的新策略:并联有机合成及库筛选[J].药学学报,1995,30(8):627-640. 被引量:5
  • 2Hülsmeyer M,Hillig RC,Volz A,et al.HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations.J Biol Chem.2002,277(49):47844 ~47853
  • 3Gonzalez-Roces S,Alvarez MV,Gonzalez S,et al.HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis.Tissue Antigens.1997,49 (2):116 ~ 123
  • 4Van der Burg SH,Drijfhout JW,Benckhuijsen WE,et al.An HLA class Ⅰ peptije-binding assay based on competition for binding to class I molecules on intact human B cells:identification of a conserved HIV-1 polymerase peptide binding to HLA-A *0301.Hum Immunol,1995,44(4):189 ~ 198
  • 5Jardetzky TS,Lane WS,Robinson RA,et al.Identification of self peptides bound to purified HLA-B27.Nature,1991,353:326 ~ 329
  • 6Ramos M,Paradela A,Vázquez M,et al.Differential association of HLA-B * 2705 and B * 2709 to Ankylosing Spondylitis correlates with limited peptide subsets but not with altered cell surface stability.J Biol Chem,2002,277 (32):28749 ~ 28756
  • 7Fukazawa T,Wang J,Huang F,et al.Testing the important of each residue in a HLA-B27 binding peptide using monoclonal antibodies.I Immunol 1994,152:1190 ~ 1197
  • 8Sherev T,Wiesmuller KH,Walden P.Mimotopes of tumorassociated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries.Mol Biotechnol.2003,25 (1):53 ~ 61
  • 9蒋黎华,范丽安,杨珏琴,姚芳娟,周嘉陵,许荣,高培娣.强直性脊椎炎与HLA-B27等位基因研究[J].中国免疫学杂志,1997,13(6):345-348. 被引量:22
  • 10蒋黎华,杨珏琴,姚芳娟,范丽安,周嘉陵,许荣,钟丽民.强直性脊椎炎病人HLA B27等位基因与HLA A、B 抗原关系分析[J].中华微生物学和免疫学杂志,1999,19(5):403-405. 被引量:6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部